These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 7524924)
41. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Fukuda I; Hizuka N; Ishikawa Y; Yasumoto K; Murakami Y; Sata A; Morita J; Kurimoto M; Okubo Y; Takano K Growth Horm IGF Res; 2006 Aug; 16(4):211-6. PubMed ID: 16860583 [TBL] [Abstract][Full Text] [Related]
42. Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Frost RA; Fuhrer J; Steigbigel R; Mariuz P; Lang CH; Gelato MC Clin Endocrinol (Oxf); 1996 May; 44(5):501-14. PubMed ID: 8762726 [TBL] [Abstract][Full Text] [Related]
43. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Lassarre C; Binoux M Endocrinology; 1994 Mar; 134(3):1254-62. PubMed ID: 7509737 [TBL] [Abstract][Full Text] [Related]
44. The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia. Baxter RC Horm Res; 1996; 46(4-5):195-201. PubMed ID: 8950621 [TBL] [Abstract][Full Text] [Related]
45. A case of a giant phyllodes tumor of the breast with hypoglycemia caused by high-molecular-weight insulin-like growth factor II. Hino N; Nakagawa Y; Ikushima Y; Yoshida M; Tsuyuguchi M Breast Cancer; 2010 Apr; 17(2):142-5. PubMed ID: 19259766 [TBL] [Abstract][Full Text] [Related]
47. Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1. Hurley MM; Abreu C; Hakeda Y J Bone Miner Res; 1995 Feb; 10(2):222-30. PubMed ID: 7538725 [TBL] [Abstract][Full Text] [Related]
48. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [TBL] [Abstract][Full Text] [Related]
49. Insulin-like growth factors in patients with nonislet cell tumors and hypoglycemia. Merimee TJ Metabolism; 1986 Apr; 35(4):360-3. PubMed ID: 2421134 [TBL] [Abstract][Full Text] [Related]
50. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Dynkevich Y; Rother KI; Whitford I; Qureshi S; Galiveeti S; Szulc AL; Danoff A; Breen TL; Kaviani N; Shanik MH; Leroith D; Vigneri R; Koch CA; Roth J Endocr Rev; 2013 Dec; 34(6):798-826. PubMed ID: 23671155 [TBL] [Abstract][Full Text] [Related]
51. Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4. Ceda GP; Fielder PJ; Henzel WJ; Louie A; Donovan SM; Hoffman AR; Rosenfeld RG Endocrinology; 1991 Jun; 128(6):2815-24. PubMed ID: 1709857 [TBL] [Abstract][Full Text] [Related]
52. Direct detection of insulin-like growth factor II (IGF-II) by chemiluminescence without interference by IGF binding proteins. De León DD; Terry C; Nissley SP Endocrinology; 1994 Apr; 134(4):1960-3. PubMed ID: 7511096 [TBL] [Abstract][Full Text] [Related]
53. Rapid clearance of insulin-like growth factor (IGF)-binding protein species from blood and an associated fall in circulating IGF-I following partial hepatectomy in the rat. Phillips ID; Arany E; Strain AJ; Han VK; Hill DJ J Endocrinol; 1993 May; 137(2):271-80. PubMed ID: 7686958 [TBL] [Abstract][Full Text] [Related]
54. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. Vollenhoven BJ; Herington AC; Healy DL J Clin Endocrinol Metab; 1993 May; 76(5):1106-10. PubMed ID: 7684390 [TBL] [Abstract][Full Text] [Related]
55. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3. Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289 [TBL] [Abstract][Full Text] [Related]
56. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979 [TBL] [Abstract][Full Text] [Related]
57. Abnormal processing of pro-IGF-II in patients with hepatoma and in some hepatitis B virus antibody-positive asymptomatic individuals. Daughaday WH; Wu JC; Lee SD; Kapadia M J Lab Clin Med; 1990 Oct; 116(4):555-62. PubMed ID: 2170553 [TBL] [Abstract][Full Text] [Related]
58. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Reeve JG; Morgan J; Schwander J; Bleehen NM Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401 [TBL] [Abstract][Full Text] [Related]
59. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. Tham A; Nordberg A; Grissom FE; Carlsson-Skwirut C; Viitanen M; Sara VR J Neural Transm Park Dis Dement Sect; 1993; 5(3):165-76. PubMed ID: 7690227 [TBL] [Abstract][Full Text] [Related]